Stock BNTX BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BioNTech SE

Equities

BNTX

US09075V1026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
87.21 USD +0.58% Intraday chart for BioNTech SE +0.46% -17.37%
Apr. 25 Sector Update: Health Care Stocks Drop in Afternoon Trading MT
Apr. 25 GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Big pharma giants in English High Court for global Covid dispute
AQ
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GL
BioNTech : Invitation to the Annual General Meeting 2024 - Form 6-K
PU
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
AQ
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
GL
WuXi Biologics Reports Solid 2023 Annual Results
AQ
BioNTech : DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K - Form 6-K
PU
BioNTech : Nachhaltigkeitsbericht 2023
PU
Sustainability Report: 2023
PU
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GL
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GL
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
PR
Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky
PR
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioNTech SE (BNTX)
BU
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
GL
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
AQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX
PR
BNTX DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
NE
BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit
PR
BioNTech Announces Planned Retirement of Sean Marett
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. News BioNTech SE
  5. Press Releases